SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Titel:
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Auteur:
Borghaei, H. de Marinis, F. Dumoulin, D. Reynolds, C. Theelen, W.S.M.E. Percent, I. Gutierrez Calderon, V. Johnson, M.L. Madroszyk-Flandin, A. Garon, E.B. He, K. Planchard, D. Reck, M. Popat, S. Herbst, R.S. Leal, T.A. Shazer, R.L. Yan, X. Harrigan, R. Peters, S.